Use

Neo Comprehensive - Solid Tumor (now NEO PanTracer Tissue) is a comprehensive next‑generation sequencing (NGS) solid tumor profiling assay designed for pan‑cancer indications. It detects genomic alterations including single nucleotide variants (SNVs), insertions/deletions (InDels), copy number variants (CNVs), fusions and splice variants by DNA and RNA sequencing, and assesses immunotherapy biomarkers such as microsatellite instability (MSI) and tumor mutational burden (TMB), supporting diagnosis, therapy selection, prognosis, and clinical trial eligibility.